Emory University

Emory University

Contents

Location

Winship Cancer Institute

Emory University
1365-C Clifton Road, NE
Atlanta, GA 30322

Physician	Jeff Olson, MD	Surasak Phuphanich, MD	Ian Crocker, MD
Specialty	Neurosurgery	Neuro-Oncology	Radiation Oncology
Address	Emory University Department of Neurosurgery 1365 Clifton Road, NE Atlanta, GA 30322	Emory University Winship Cancer Center 1365 Clifton Road, NE, Suite. C-2080 Atlanta, GA 30322	Emory University Radiation Oncology 1365-A Clifton Road, NE Atlanta, GA 30322
Phone Number	404-778-3091	404-778-2214	404-778-3662
Email	jeffrey_olson@emory.org	s_phuphanich@emoryhealthcare.org	ian_crocker@emoryhealthcare.org

NABTT Protocol Availability

Class A: (Newly Diagnosed Glioblastoma Multiforme with Measurable Disease)

Phase I/II Trial of Oxaliplatin as Neoadjuvant Treatment in Adults with Newly Diagnosed Malignant Glioma

Class B: (Newly Diagnosed Glioblastoma Multiforme, Measurable/Non Measurable Disease)

Phase I Study of Combined Radiotherapy and Arsenic Trioxide for the Treatment of Newly Diagnosed Malignant Gliomas
A Safety Run-In/Randomized Phase II Trial of EMD 121974 in Conjunction with Concomitant and Adjuvant Temozolomide with Radiation Therapy in Patients with Newly Diagnosed Glioblastoma Multiforme

Class C: (Recurrent High Grade Astrocytoma, with Measurable Disease)

Phase I Evaluation of the Safety of PS341 in the Treatment of Recurrent Gliomas
A Phase I/II Trial of BMS-247550 for Treatment of Patients with Recurrent High Grade Gliomas
A Phase I, Open-Label, Non-Randomized, Multicenter, Single Agent Study of Intravenous SDX-102 for the Treatment of Patients with MTAP-Deficient High Grade Recurrent Malignant Gliomas
A Phase I Trial of BAY 43-9006 for Patients with Recurrent or Progressive Malignant Glioma

Class D: (Locally Recurrent High Grade Astrocytoma)

A Pharmacokinetic Study of Methotrexate Using an Intratumoral Microdialysis Catheter
An Open-label, Dose Confirmation and Dosimetry Study of Interstitial ¹³¹I-chTNT-1/B MAb (COTARA™) For the Treatment of Glioblastoma Multiforme (GBM) at 1^st or 2^nd Relapse

Class E: (Histology other than High Grade Astrocytoma)

A Phase II Study of Anti-CD20 Monoclonal Antibody (Rituximab) Therapy for Patients with Refractory or Relapsed Primary Central Nervous System Lymphoma (PCNSL)

Class F: (Non-therapeutic Protocols)

For information regarding the protocols available at this center, please contact:

Ellen McKenzie RN, CCRC
Senior Research Nurse
1365-C Clifton Road, NE
Atlanta, GA 30322
Telephone: 404-778-5344
ellen_mckenzie@emory.org